The American Feed Industry Association has welcomed the approval of Aquaflor
AFIA spokesman, Richard Sellers said the association believes the approval of the new catfish animal drug, florfenicol (Aquaflor), as a veterinary feed directive drug will assist in the judicious use of this new drug - the first new aquaculture drug in more than 20 years.
“AFIA is continuing to assist the drug sponsor, Schering-Plough Animal Health, catfish producers and the feed industry in understanding the requirements of the VFD system and is hosting a VFD workshop during Aquaculture
Florfenicol (Aquaflor®), permitted for use in controlling conditions in catfish, hybrid striped bass, salmonids, and tilapia.